Daewoong Pharmaceutical Competitors and Similar CompaniesClear all

Daewoong Pharmaceutical's competitors and similar companies include Abiomed, PROBIOMED, Ali Raif and Seriki and B. Braun Medical.

	Daewoong Pharmaceutical Daewoong Pharmaceutical (대웅제약) is a company that provides pharmaceutical solutions and services.	Abiomed Abiomed is a company providing medical devices for circulatory support.	PROBIOMED PROBIOMED is a biopharmaceutical company.	Ali Raif and Seriki Ali Raif and Seriki (ARIS) is a manufacturer of pharmaceutical products.	B. Braun Medical B. Braun Medical is a company that develops, manufactures, and markets medical products and services.
Founding Date	Founding Date 2002	Founding Date 1981	Founding Date 1970	Founding Date 1963	Founding Date 1957
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Private	Type Subsidiary
Tags	Tags Healthcare drug development medical devices pharma	Tags Healthcare medical devices pharma	Tags Healthcare medical devices pharma	Tags Healthcare medical devices pharma	Tags Healthcare medical devices nutrition pharma
Locations	Locations Seoul, KR HQ Hyderabad, IN Taguig City, PH Bangkok, TH	Locations Danvers, US HQ Aachen, DE Tokyo, JP Halethorpe, US	Locations Ciudad de México, MX HQ Ciudad De México, MX Ciudad De México, MX Tenancingo De Degollado, MX	Locations Istanbul, TR HQ Adana, TR Ankara, TR Antalya, TR Bursa, TR Di̇yarbakir, TR İstanbul, TR see more	Locations Bethlehem, US HQ Allentown, US
Employees	Employees 1,669	Employees 2,00316% increase	Employees 662	Employees 7341% increase	Employees 5,476
Financial
Revenue (est.)	Revenue (est.) ₩2.1t (FY, 2025)	Revenue (est.) $1b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods (₩2b) (FY, 2025)	Cost of goods $188.2m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ₩2.1t (FY, 2025)	Gross profit $843.6m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ₩227.9b (FY, 2025)	Net income $136.5m (FY, 2022)	Net income N/A	Net income N/A	Net income N/A